Hydrogel-Based Cell Encapsulation: A Potential Game-Changer for Type 1 Diabetes By Dr. Natalie Singh, Health Editor | May 18, 2026 For the 9.5 million people worldwide living with Type 1 …
Tag:
Pancreas
-
-
Health
Cellular Pathways from Pancreatic Lesions to Cancer Identified: Key Insights for Early Detection and Progression Understanding
To create a comprehensive and factually accurate article on the topic of pancreatic cancer, particularly focusing on metabolic pathways and their role in disease progression and therapeutic opportunities, I will …
-
Health
Pancreatic Cancer: New Study Targets Prevention at Earliest Stage | KRAS Mutation & PanIN Lesions
AI and Early Detection Offer New Hope in the Fight Against Pancreatic Cancer Pancreatic cancer remains one of the deadliest cancers, with a five-year survival rate of less than 10%, …
-
Cancer Interception: New Approach Shows Promise in Pancreatic Cancer Models A new preclinical study in mice demonstrates that eliminating precancerous cells in the pancreas before they develop into tumors is …
-
Enrica Bonaccorti, Italian TV Pioneer, Dies at 76 Enrica Bonaccorti, a prominent figure in Italian television, passed away on Thursday, March 12, 2026, at the age of 76, following a …
-
Iron’s Crucial Role in Beta Cell Development and Diabetes Prevention A groundbreaking study led by researchers at the Vrije Universiteit Brussel (VUB) and UZ Brussel has revealed a critical link …
-
Pancreatic Cancer’s Early Immune Evasion Tactics Revealed New research indicates that pancreatic cancer may initiate to evade the immune system much earlier than previously thought, potentially years before clinical detection. …
-
Olaparib Gains Reimbursement in Italy for Advanced Pancreatic Cancer with BRCA Mutations A new treatment option is now available for patients in Italy battling metastatic pancreatic cancer with BRCA1/2 mutations. …
-
Latest Chemotherapy Combination Shows Promise for Pancreatic Cancer Patients Bologna, Italy – February 23, 2026 – A novel chemotherapy regimen is offering renewed hope for individuals battling pancreatic cancer, potentially …
-
Olaparib Receives Reimbursement for Advanced Pancreatic Cancer with BRCA Mutations The Italian Medicines Agency (AIFA) has approved the reimbursement of olaparib, a PARP inhibitor, for the maintenance treatment of patients …
Newer Posts